Coloplast A/S Is Good To Go

Every New York stock exchange trading day I'm posting a daily dividend stock or fund review. I'll share the three chief qualities of just one equity or fund that could be selected for a dividend stock portfolio I've named the Safari to Sweet Success.

This week's slot in the Safari portfolio is reserved for the Healthcare sector.

That sector includes ten industries all related to testing, diagnosing and curing what ails us. The healthcare industries are: biotechnology; diagnostics & research; drug manufacturers - major; drug manufacturers - specialty & generic; healthcare plans; long-term care facilities; medical care; medical devices, medial distribution; medical supplies.

Today I'm reviewing medical instruments and supplies industry firm named Coloplast A/S. Its trading ticker symbol is CLPBY.

Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Urology Care, and Wound & Skin Care. Some of its products are ostomy bags under the SenSura brand, ostomy accessories under the Brava brand, and SpeediCath catheters.

Coloplast A/S was founded in 1954 and is headquartered in Denmark.

I use three primary keys to measure dividend equities or funds like Coloplast A/S (CLPBY): 

(1) Price

(2) Dividends

(3) Returns

CLPBY Price

Coloplast A/S's price at yesterday's market close was $8.10 per share. The company has positive momentum. Just a year ago its price was $6.89. That's a gain of $1.21 per share in the past year.Can CLPBY do as well in the coming year?If it does, its price will increase from $8.10 to $9.31 per share or about 15 %.

CLPBY Dividends

The company's most recent variable semi-annual dividend was $0.1645 declared in November 2017 and paid December 27th. 

The company has paid eight semi-annual dividends in May and December each year since2014.

The consensus forward-looking annual dividend for 2018 is $0.33 paid in May and December.

The yield from a $0.33 dividend at yesterday's $8.10 price is 4.1%

Are Gains Ahead For CLPBY?

Adding the $0.33 dividend to the $1.21 potential gain from a repeat of 2017's price performance projects a possible $1.54 gross gain.  

The outcome for CLPBY depends on how many shares are bought. A $1,000.00 budget for shares at yesterday's $8.10 closing price would let us purchase 123 shares. 

Those 123 shares will be hit with a broker fee of $5 at purchase and another $5 at sale (for a total of $10 to get the gains). Each share then has a brokerage cost of about $0.8

Subtracting an $0.8 brokerage cost from the estimated $1.54 gross gain shows a net gain to 2019 of $1.46 X 123 shares = $179.58 or about a 18% net gain on our $996.30 investment.

Therefore, Coloplast A/S (whose ticker symbol is CLPBY), shows a possible 18% gain by my simple year over year calculation with a 4.1% dividend baked in.

These forward-looking numbers are conjecture based on past year performance. The actual results remain to be seen.They could turn out to move lower. More study is required for you to determine if Coloplast A/S (CLPBY) is worth your time and money.